Unlock your academic potential and expand your network by joining us!

Rejean Couture

Dr. Rejean Couture

Department of Pharmacology and Physiology, Faculty of Medicine, Université de Mo...

Share Link

Share

Information

Réjean Couture received his PhD in Pharmacology (1981) from the Université de Sherbrooke, Quebec, Canada, and did two postdoctoral trainings, one at Oxford University, UK (1981–1983), and one at McGill University, Canada (1983–1984). He was appointed Assistant Professor in the Department of Physiology at Université de Montréal (1984) and was promoted Full Professor in Physiology (1995), which became the Department of Pharmacology and Physiology (2016), Faculty of Medicine at Universite de Montreal, Montréal, QC, Canada. He is a member of GRUM (University Drug Research Group) and has been Director of the postgraduate program in physiology for 22 years. His research focuses on the role of neuropeptides (chiefly substance P, tachykinins, and kinins) and their receptors in central mechanisms that regulate cardiovascular and nociceptive functions (pain) in hypertensive and diabetic rats. More recently, his research has been dedicated to studying the role of bradykinin and its receptors in diabetic retinopathy and age-related macular degeneration (supported by the Canadian Institutes of Health Research). He has published nearly 300 papers in various peer-reviewed journals. His interests include inflammation, diabetes, hypertension, vasoactive peptides, oxidative stress, pharmacology, physiology, and neuroscience.

Research Keywords & Expertise

Diabetes
Epilepsy
Inflammation
Alzheimer Disease
ocular diseases

Short Biography

Réjean Couture received his PhD in Pharmacology (1981) from the Université de Sherbrooke, Quebec, Canada, and did two postdoctoral trainings, one at Oxford University, UK (1981–1983), and one at McGill University, Canada (1983–1984). He was appointed Assistant Professor in the Department of Physiology at Université de Montréal (1984) and was promoted Full Professor in Physiology (1995), which became the Department of Pharmacology and Physiology (2016), Faculty of Medicine at Universite de Montreal, Montréal, QC, Canada. He is a member of GRUM (University Drug Research Group) and has been Director of the postgraduate program in physiology for 22 years. His research focuses on the role of neuropeptides (chiefly substance P, tachykinins, and kinins) and their receptors in central mechanisms that regulate cardiovascular and nociceptive functions (pain) in hypertensive and diabetic rats. More recently, his research has been dedicated to studying the role of bradykinin and its receptors in diabetic retinopathy and age-related macular degeneration (supported by the Canadian Institutes of Health Research). He has published nearly 300 papers in various peer-reviewed journals. His interests include inflammation, diabetes, hypertension, vasoactive peptides, oxidative stress, pharmacology, physiology, and neuroscience.